Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lena Allweiss

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2025
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis DeltaPietro Lampertico, Pavel O Bogomolov, Vladimir Chulanov, et al.
Hepatology (Baltimore, Md.)|January 12, 2020
Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human HepatocytesZhenhua Zhang, Martin Trippler, Catherine I Real, et al.
The Lancet. Neurology|October 8, 2020
Neuropathology of patients with COVID-19 in Germany: a post-mortem case seriesJakob Matschke, Marc Lütgehetmann, Christian Hagel, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cellsJan-Hendrik Bockmann, Lena Allweiss, Annika Volmari, et al.
Scientific Reports|May 19, 2026
Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humansFabian Heinrich, Jöran Lücke, Siwen Zhang, et al.
Plos Computational Biology|January 9, 2025
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markersKwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, et al.
The Lancet. Infectious Diseases|September 16, 2022
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trialHeiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
The Journal of General Virology|May 17, 2024
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus, Lena Allweiss, Chari Cohen, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2025
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis DeltaPietro Lampertico, Pavel O Bogomolov, Vladimir Chulanov, et al.
Hepatology (Baltimore, Md.)|January 12, 2020
Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human HepatocytesZhenhua Zhang, Martin Trippler, Catherine I Real, et al.
The Lancet. Neurology|October 8, 2020
Neuropathology of patients with COVID-19 in Germany: a post-mortem case seriesJakob Matschke, Marc Lütgehetmann, Christian Hagel, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cellsJan-Hendrik Bockmann, Lena Allweiss, Annika Volmari, et al.
Scientific Reports|May 19, 2026
Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humansFabian Heinrich, Jöran Lücke, Siwen Zhang, et al.
Plos Computational Biology|January 9, 2025
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markersKwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, et al.
The Lancet. Infectious Diseases|September 16, 2022
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trialHeiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
The Journal of General Virology|May 17, 2024
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus, Lena Allweiss, Chari Cohen, et al.
Pageof 5